Cephalovac EWT

Manufacturer: Boehringer Ingelheim

Encephalomyelitis Vaccine, Eastern And Western, Killed Virus, Tetanus Toxoid

Cephalovac EWT Indications

For the vaccination of all types and ages of healthy horses against Eastern and Western Equine Encephalomyelitis and tetanus.

Administration And Dosage

Shake well before using. Using aseptic technique, inject 2 mL deep intramuscularly. Administer a second 2 mL dose in 4 to 6 weeks, using a different injection site. Revaccinate annually and prior to anticipated exposure, using a single 2 mL dose. Use a separate, sterile 1 1/2 inch needle for each injection.

Cephalovac EWT Caution

Store at 35-45°F (2-7°C). Protect from freezing. Use entire contents when first opened. Contains gentamicin and thimerosal as preservatives. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use.

Antidote

Epinephrine.

Precaution

This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal healthy animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.

For Veterinary Use Only

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Mo 64506 U.s.a.

U.s. Veterinary License No. 124

Code
131-115	10 x 1 dose (2 mL) syringes	31101-03, 31102-03
131-125	10 Doses/20 mL	31103-03, 31104-04

Nac No.

10280282